Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells

Although Chk1 kinase inhibitors are currently under clinical investigation as effective cancer cell sensitizers to the cytotoxic effects of numerous chemotherapeutics, there is still a considerable uncertainty regarding their role in modulation of anticancer potential of platinum-based drugs. Here w...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neoplasia
Egile Nagusiak: Herůdková, Jarmila, Paruch, Kamil, Khirsariya, Prashant, Souček, Karel, Krkoška, Martin, Vondálová Blanářová, Olga, Sova, Petr, Kozubík, Alois, Hyršlová Vaculová, Alena
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Neoplasia Press 2017
Gaiak:
Original article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5591453/
https://ncbi.nlm.nih.gov/pubmed/28888100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2017.08.002
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak